Quantitative Evaluation of Therapeutic Response by FDG-PET-CT in Metastatic Breast Cancer

被引:11
作者
Goulon, Dorothee [1 ]
Necib, Hatem [2 ]
Henaff, Brice [3 ]
Rousseau, Caroline [1 ]
Carlier, Thomas [3 ,4 ]
Kraeber-Bodere, Francoise [3 ,4 ]
机构
[1] ICO Nantes, Serv Med Nucl, St Herblain, France
[2] CHU Nantes, Serv Radiol, Nantes, France
[3] CHU Nantes, Serv Med Nucl, Nantes, France
[4] INSERM, UM R892, Nantes, France
关键词
FDG; PET; breast cancer; PERCIST; therapeutic evaluation; parametric analysis; SULTAN; POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG PET; NEOADJUVANT CHEMOTHERAPY; EARLY PREDICTION; METABOLIC-RESPONSE; SYSTEMIC THERAPY; SOLID TUMORS; STAGE-II; FLUORODEOXYGLUCOSE; RECOMMENDATIONS;
D O I
10.3389/fmed.2016.00019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To assess the therapeutic response for metastatic breast cancer with F-18-FDG position emission tomography (PET), this retrospective study aims to compare the performance of six different metabolic metrics with PERCIST, PERCIST with optimal thresholds, and an image-based parametric approach. Methods: Thirty-six metastatic breast cancer patients underwent 128 PET scans and 123 lesions were identified. In a per-lesion and per-patient analysis, the performance of six metrics: maximum standardized uptake value (SUVmax), SUVpeak, standardized added metabolic activity (SAM), SUVmean, metabolic volume (MV), total lesion glycolysis (TLG), and a parametric approach (SULTAN) were determined and compared to the gold standard (defined by clinical assessment and biological and conventional imaging according RECIST 1.1). The evaluation was performed using PERCIST thresholds (for per-patient analysis only) and optimal thresholds (determined by the Youden criterion from the receiver operating characteristic curves). Results: In the per-lesion analysis, 210 pairs of lesion evolutions were studied. Using the optimal thresholds, SUVmax, SUVpeak, SUVmean, SAM, and TLG were significantly correlated with the gold standard. SUVmax, SUVpeak, and SUVmean reached the best sensitivity (91, 88, and 83%, respectively), specificity (93, 95, and 97%, respectively), and negative predictive value (NPV, 90, 88, and 83%, respectively). For the per-patient analysis, 79 pairs of PET were studied. The optimal thresholds compared to the PERCIST threshold did not improve performance for SUVmax, SUVpeak, and SUVmean. Only SUVmax, SUVpeak, SUVmean, and TLG were correlated with the gold standard. SULTAN also performed equally: 83% sensitivity, 88% specificity, and NPV 86%. Conclusion: This study showed that SUVmax and SUVpeak were the best parameters for PET evaluation of metastatic breast cancer lesions. Parametric imaging is helpful in evaluating serial studies.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 37 条
[1]   18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer [J].
Avril, Stefanie ;
Muzic, Raymond F., Jr. ;
Plecha, Donna ;
Traughber, Bryan J. ;
Vinayak, Shaveta ;
Avril, Norbert .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 :34S-39S
[2]   [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy [J].
Berriolo-Riedinger, Alina ;
Touzery, Claude ;
Riedinger, Jean-Marc ;
Toubeau, Michel ;
Coudert, Bruno ;
Arnould, Laurent ;
Boichot, Christophe ;
Cochet, Alexandre ;
Fumoleau, Pierre ;
Brunotte, Francois .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (12) :1915-1924
[3]  
Boellaard R, 2004, J NUCL MED, V45, P1519
[4]  
Cachin F, 2006, B CANCER, V93, P1191
[5]   State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET [J].
Carlier, Thomas ;
Bailly, Clement .
FRONTIERS IN MEDICINE, 2015, 2 :18
[6]   Sequential positron emission tomography using [18F] fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer [J].
Couturier, Olivier ;
Jerusalem, Guy ;
N'Guyen, Jean-Michel ;
Hustinx, Roland .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6437-6443
[7]  
Duch J, 2012, Q J NUCL MED MOL IM, V56, P291
[8]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[9]   FAMIS - A SOFTWARE PACKAGE FOR FUNCTIONAL FEATURE-EXTRACTION FROM BIOMEDICAL MULTIDIMENSIONAL IMAGES [J].
FROUIN, F ;
BAZIN, JP ;
DIPAOLA, M ;
JOLIVET, O ;
DIPAOLA, R .
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 1992, 16 (02) :81-91
[10]   Effect of 18F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer [J].
Groheux, David ;
Moretti, Jean-Luc ;
Baillet, Georges ;
Espie, Marc ;
Giacchetti, Sylvff ;
Hindie, Elff ;
Hennequin, Christophe ;
Vilcoq, Jacques-Robert ;
Cuvier, Caroline ;
Toubert, Marie-Elisabeth ;
Filmont, Jean-Emmanuel ;
Sarandi, Farid ;
Misset, Jean-Louis .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03) :695-704